JW Pharmaceutical Corporation (001060.KS) KSC

26,850.00

-600(-2.19%)

Updated at December 24 03:30PM

Currency In KRW

Valuation

Market Cap559.8B
Enterprise Value641.1B
P/E Ratio10.32
PEG Ratio0.47
Price/Sales Ratio0.81
Price/Book Ratio1.83
Enterprise/Revenue0.86
Enterprise/EBITDA3.53

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.13

Management Effectiveness

Return On Assets0.1
Return On Equity0.19

Income Statement

Revenue719.38B
Revenue/Share31,654.73
Gross Profit323.5B
EBITDA110.17B
Net Income65.04B
Diluted EPS2,644.47

Balance Sheet

Total Cash82.51B
Total Cash/Share3,417.81
Total Debt68.66B
Total Debt/Equity0.19
Current Ratio1.51
Book Value Per Share14,667.38

Price History

52-Week Change12.11
52-Week High29,950
52-Week Low19,600
Moving Average 50 Days25,238
Moving Average 200 Days22,913.95

Statistics

Average Volume84,948
Shares Outstanding23.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate450
Trailing Annual Dividend Yield1.68
Payout Ratio0.18
Last Split Factor51:50
Last Split DateDecember 27, 2023